122 related articles for article (PubMed ID: 37922697)
1. Antimicrobial and antibiofilm activities of chromone derivatives against uropathogenic Escherichia coli.
Boya BR; Lee JH; Lee J
Microbiol Res; 2024 Jan; 278():127537. PubMed ID: 37922697
[TBL] [Abstract][Full Text] [Related]
2. Discovery of New Genes Involved in Curli Production by a Uropathogenic Escherichia coli Strain from the Highly Virulent O45:K1:H7 Lineage.
Nhu NTK; Phan MD; Peters KM; Lo AW; Forde BM; Min Chong T; Yin WF; Chan KG; Chromek M; Brauner A; Chapman MR; Beatson SA; Schembri MA
mBio; 2018 Aug; 9(4):. PubMed ID: 30131362
[TBL] [Abstract][Full Text] [Related]
3. Antibiofilm and Antimicrobial Activities of Chloroindoles Against Uropathogenic
Boya BR; Lee JH; Lee J
Front Microbiol; 2022; 13():872943. PubMed ID: 35783430
[TBL] [Abstract][Full Text] [Related]
4. Correlation between antimicrobial resistance, biofilm formation, and virulence determinants in uropathogenic Escherichia coli from Egyptian hospital.
Alshaikh SA; El-Banna T; Sonbol F; Farghali MH
Ann Clin Microbiol Antimicrob; 2024 Feb; 23(1):20. PubMed ID: 38402146
[TBL] [Abstract][Full Text] [Related]
5. BarA-UvrY two-component system regulates virulence of uropathogenic E. coli CFT073.
Palaniyandi S; Mitra A; Herren CD; Lockatell CV; Johnson DE; Zhu X; Mukhopadhyay S
PLoS One; 2012; 7(2):e31348. PubMed ID: 22363626
[TBL] [Abstract][Full Text] [Related]
6. Siderophore Biosynthesis Governs the Virulence of Uropathogenic Escherichia coli by Coordinately Modulating the Differential Metabolism.
Su Q; Guan T; He Y; Lv H
J Proteome Res; 2016 Apr; 15(4):1323-32. PubMed ID: 26954697
[TBL] [Abstract][Full Text] [Related]
7. [Research on mechanisms of drug resistance and virulence expression in pathogenic Escherichia coli].
Hirakawa H
Nihon Saikingaku Zasshi; 2023; 78(3):167-177. PubMed ID: 37880099
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections.
Zhao F; Yang H; Bi D; Khaledi A; Qiao M
Microb Pathog; 2020 Jul; 144():104196. PubMed ID: 32283258
[TBL] [Abstract][Full Text] [Related]
9. Ferric Citrate Uptake Is a Virulence Factor in Uropathogenic Escherichia coli.
Frick-Cheng AE; Sintsova A; Smith SN; Pirani A; Snitkin ES; Mobley HLT
mBio; 2022 Jun; 13(3):e0103522. PubMed ID: 35546538
[TBL] [Abstract][Full Text] [Related]
10. The anti-biofilm and anti-virulence activities of
Lee JH; Kim YG; Raorane CJ; Ryu SY; Shim JJ; Lee J
Biofouling; 2019 Aug; 35(7):758-767. PubMed ID: 31505984
[TBL] [Abstract][Full Text] [Related]
11. Carvacrol-rich oregano oil and thymol-rich thyme red oil inhibit biofilm formation and the virulence of uropathogenic Escherichia coli.
Lee JH; Kim YG; Lee J
J Appl Microbiol; 2017 Dec; 123(6):1420-1428. PubMed ID: 28980415
[TBL] [Abstract][Full Text] [Related]
12. Uropathogenic
Alfuraiji N; Al-Hamami A; Ibrahim M; Rajab HK; Hussain BW
J Med Life; 2022 May; 15(5):650-654. PubMed ID: 35815089
[TBL] [Abstract][Full Text] [Related]
13. Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors.
Hadjifrangiskou M; Gu AP; Pinkner JS; Kostakioti M; Zhang EW; Greene SE; Hultgren SJ
J Bacteriol; 2012 Nov; 194(22):6195-205. PubMed ID: 22984258
[TBL] [Abstract][Full Text] [Related]
14. Roles of OmpX, an Outer Membrane Protein, on Virulence and Flagellar Expression in Uropathogenic Escherichia coli.
Hirakawa H; Suzue K; Takita A; Kamitani W; Tomita H
Infect Immun; 2021 May; 89(6):. PubMed ID: 33753414
[TBL] [Abstract][Full Text] [Related]
15. Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance.
Shah C; Baral R; Bartaula B; Shrestha LB
BMC Microbiol; 2019 Sep; 19(1):204. PubMed ID: 31477018
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic Assessment of Clinical Escherichia coli Isolates as an Indicator for Uropathogenic Potential.
Shea AE; Frick-Cheng AE; Smith SN; Mobley HLT
mSystems; 2022 Dec; 7(6):e0082722. PubMed ID: 36445110
[TBL] [Abstract][Full Text] [Related]
17. Effect of sub-minimal inhibitory concentration ceftazidime on the pathogenicity of uropathogenic Escherichia coli.
Feng W; Zhang L; Yuan Q; Wang Y; Yao P; Xia P; Sun F
Microb Pathog; 2021 Feb; 151():104748. PubMed ID: 33484810
[TBL] [Abstract][Full Text] [Related]
18. Virulence behavior of uropathogenic Escherichia coli strains in the host model Caenorhabditis elegans.
Schifano E; Marazzato M; Ammendolia MG; Zanni E; Ricci M; Comanducci A; Goldoni P; Conte MP; Uccelletti D; Longhi C
Microbiologyopen; 2019 Jun; 8(6):e00756. PubMed ID: 30381890
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.
Nagamatsu K; Hannan TJ; Guest RL; Kostakioti M; Hadjifrangiskou M; Binkley J; Dodson K; Raivio TL; Hultgren SJ
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E871-80. PubMed ID: 25675528
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
